- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04852354
Tissue Collection for Drug Screening and Bioanalysis
Study Overview
Status
Detailed Description
The goal of this project is to enable the acquisition of tissue available for research with the prospect of enabling the development of new therapeutic avenues for patients diagnosed with cancer in the central nervous system.
During pediatric patients' (with a CNS tumor) routine operative procedure, if extra tissue deemed unnecessary for diagnostic or clinical purposes is available, selected samples will undergo DNA and/or RNA extraction and integrity analysis, whole genome and RNA sequencing, DNA and RNA methylome analyses, proteomic analysis, immunoprofiling, and primary culturing of the tumor cells. These cultures may then be used for drug screenings and to create patient-derived xenografts, or for comparisons between tumor and non-tumor patients. Other biological samples may be collected.
Additionally, saliva samples may be obtained from the parents of pediatric patients with CNS tumors, and biological samples may be collected from pediatric patients without a CNS tumor who are undergoing a neurological procedure. These samples may be used for comparison with samples from patients with CNS tumors.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jeffrey Greenfield, M.D.
- Phone Number: 212-746-2363
- Email: jpgreenf@med.cornell.edu
Study Contact Backup
- Name: Colleen Sanders
- Email: clc9095@nyp.org
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Recruiting
- Weill Cornell Medicine
-
Contact:
- Jeffrey Greenfield, M.D.
- Phone Number: 212-746-2363
- Email: jpgreenf@med.cornell.edu
-
Principal Investigator:
- Jeffrey Greenfield, M.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria for tumor patient:
- Subject has presented with a suspected neoplastic CNS lesion and is undergoing a neurosurgical procedure in which CNS tissue and/or tumors associated with this tissue will be removed.
- There must be tissue available in excess of that required by neuropathology for diagnostic purposes.
Inclusion Criteria for parent of tumor patients
- Subject is the biological parent of a pediatric patient undergoing a neurosurgical procedure in which CNS tissue and/or tumors associated with this tissue will be removed.
Inclusion Criteria for non-tumor patients
- Subject is under 21 years of age and is undergoing a neurosurgical procedure at WCMC.
- Subject has never been diagnosed with a CNS neoplasm
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Pediatric tumor patients undergoing neurosurgery
Samples of tumor tissue, blood, CSF, saliva, skull, and dura will be taken during neurosurgery from tumor patients meeting the inclusion criteria.
|
Parents of tumor patients
Saliva samples will be taken from parents of pediatric tumor patients meeting the inclusion criteria.
|
Non-tumor patients
Blood and CSF samples will be taken from non-tumor pediatric patients meeting the inclusion criteria.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluating and characterizing the genetic, immunohistochemical, cellular, and molecular profiles of pediatric neoplastic lesions
Time Frame: Through study completion, average 1-3 years
|
To develop patient-derived tissue cell lines and xenografts
|
Through study completion, average 1-3 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jeffrey Greenfield, M.D., Weill Medical College of Cornell University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-01021289
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Central Nervous System Tumor
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Puerto Rico
-
Xinhua Hospital, Shanghai Jiao Tong University...CNOG-MC001 Collaborative GroupCompletedPediatric Brain Tumor | Malignant Brain Tumor | Tumors, Central Nervous System | Benign Brain TumorChina
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Central Nervous System Metastases | Childhood Central Nervous System Germ Cell Tumor | Childhood Central Nervous System Choriocarcinoma | Childhood Central Nervous System Germinoma | Childhood Central Nervous System Mixed Germ Cell Tumor | Childhood Central Nervous System Teratoma and other conditionsUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingCentral Nervous System Tumor | Somatic Mutation | Pediatric Central Nervous System Tumor | Discordant TwinUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Childhood Brain Stem Glioma | Childhood Central Nervous System Germ Cell Tumor | Childhood Central Nervous System Choriocarcinoma | Childhood Central Nervous System Germinoma | Childhood Central Nervous System Mixed Germ Cell... and other conditionsUnited States
-
University of Erlangen-Nürnberg Medical SchoolNot yet recruitingBrain Tumor, Primary | Brain Tumor - MetastaticGermany
-
University of NebraskaRecruitingPrimary Brain Tumor | Metastatic Brain TumorUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia
-
Washington University School of MedicineNot yet recruitingBrain Tumor, PrimaryUnited States